Research

At the start of the 47th Union World Conference on Lung Health in Liverpool, UK, an international group of top TB experts from...

RI-MUHC research could lead to new breast cancer treatments linked to prolactin receptor A study conducted at the Research Institute of the McGill...

Alzheimer’s disease (AD) is a devastating condition that results in cognitive impairment, loss of executive functions and dementia. It is estimated that 36...

Shawn Hayward, MNI You probably know someone who has it. It is the most common movement disorder, yet most people don’t even know...

By Dr. Thomas Schlich, Department of Social Studies of Medicine Patients’ choices and preferences are shaping surgery much more than commonly thought. Typically,...

Phase 1 trials for new drugs mark an important first step in the process of testing the safety and efficacy of potential new...

Findings will immediately improve the lives of patients with colon metastasis liver cancer and could lead to more personalized treatment options From MUHC...

Study could pave way for development of novel therapeutic approaches for inflammatory diseases McGill researchers have identified two proteins that work together to...

In a recently published review article in the Canadian Medical Association Journal (CMAJ), Dr. Anne Andermann, an associate professor in the Department of...

Discovery could lead to ways to mitigate effects of jet lag and shift work The brain’s biological clock stimulates thirst in the hours...

Each issue of the prestigious journal, Academic Medicine, concludes with a highly coveted ‘Last Page’ article. This year, two researchers from the McGill...

Discovery could benefit patients with aggressive disease In a new study published recently in the Journal of Cell Biology, researchers from McGill University’s...